VCS
MRK icon

Vaughan & Co Securities’s Merck MRK Stock Holding History

Vaughan & Co Securities’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-451
Closed -$33.1K – 122
2020
Q1 		$33.1K Sell
451
-60
-12% -$4.72K 0.04% 97
2019
Q4 		$44.4K Buy
+511
New +$42K 0.04% 95

Other funds holding MRK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vaughan & Co Securities's MRK Position: Q2 2020 in Review

Vaughan & Co Securities sold out of Merck (MRK) in Q2 2020, closing a stake of 451 shares — an estimated $33.1K sold.

Vaughan & Co Securities first reported a position in MRK in Q4 2019 and held it in 2 quarters. The position peaked at $44.4K in Q4 2019. 2,495 funds tracked by Wall St. Rank hold MRK as of Q2 2020.

  • Vaughan & Co Securities reported no remaining Merck position as of Q2 2020 after selling out during the quarter.
  • Vaughan & Co Securities sold 451 Merck shares in Q2 2020, an estimated $33.1K.
  • Vaughan & Co Securities first reported a position in Merck in Q4 2019 and held it in 2 quarters.
  • Vaughan & Co Securities's Merck position peaked at $44.4K in Q4 2019.
  • 2,495 funds tracked by Wall St. Rank held Merck as of Q2 2020.

Based on Vaughan & Co Securities's 13F filing for Q2 2020, filed 10 May 2021.